Guidelines

Archive

Sr. No.TitleDocument
1Annual Report: Antimicrobial Resistance Surveillance and Research Network (Jan 2023-Dec 2023)PDF Icon(12.4 MB)
2Annual Report: Antimicrobial Resistance Surveillance and Research Network (Jan 2022-Dec 2022)PDF Icon(39.8 MB)
1Treatment Guidelines For Antimicrobial Use in Common Syndromes 2022PDF IconPlease scan QR Code to get the link
4Annual Report: Antimicrobial Resistance Surveillance and Research Network (Jan 2021-Dec 2021)PDF Icon(7.80 MB)
2Guidance on Diagnosis & Management of Carbapenem Resistant Gram-negative InfectionsPDF Icon(1.77 MB)
6Annual Report: Antimicrobial Resistance Surveillance and Research Network (Jan 2020-Dec 2020)PDF Icon(9.96 MB)
7Annual Report: Antimicrobial Resistance Surveillance and Research Network (Jan 2019-Dec 2019)PDF Icon(4.82 MB)
32019-Enabling AMR-related Clinical Trials in India: Network Exploratory WorkshopPDF Icon(1.06 MB)
42019-Treatment Guidelines for Antimicrobial Use in Common Syndromes-2nd editionPDF Icon(4.69 MB)
52019-National Essential Diagnostics ListPDF Icon(1.54 MB)
62019-Standard Operating Procedures - Bacteriology-2nd editionPDF Icon(3.88 MB)
72019-Standard Operating Procedures - Mycology Laboratories-2nd editionPDF Icon(4.13 MB)
82019-Standard Operating Procedures- Bacteriology- Veterinary SectorPDF Icon(2.24 MB)
92018-Antimicrobial Stewardship Program GuidelinePDF Icon(1.82 MB)
102017-Hospital Infection Control GuidelinesPDF Icon(731.88 KB)
112017-Candida Auris AdvisoryPDF Icon(245.12 KB)
122017-Treatment Guidelines for Antimicrobial Use in Common Syndromes-1st editionPDF Icon(3.51 MB)
132016-Standard Operating Procedures - Bacteriology-1st editionPDF Icon(2.46 MB)
142016-Standard Operating Procedures - Mycology Laboratories-1st edition Antimicrobial Resistance (1.60 MB)PDF Icon(1.60 MB)
Sr. No.TitleDocument
1General Guidelines for Establishment of Biosafety Level-3 LaboratoryPDF Icon(2.79 MB)
2Map for Biosafety Level-3 LaboratoryPDF Icon(641 KB)
Sr. No.TitleDocument
1Acute Myeloid LeukemiaPDF Icon(8.45 MB)
2Cancer MonographPDF Icon(16.16 MB)
3Consensus document for Management of Pediatric Lymphoma.PDF Icon(15.56 MB)
4Consensus Document for Management of Hepatocellular Carcinoma.PDF Icon(7.58 MB)
5Consensus Document for Management of Neuroendocrine Tumours.PDF Icon(7.99 MB)
6Consensus Document for Management of Pancreatic CancerPDF Icon(4.12 MB)
7Breast CancerPDF Icon(5.87 MB)
8Buccal Mucosa CancerPDF Icon(2.43 MB)
9Cancer ResearchPDF Icon(565.56 KB)
10Cervix CancerPDF Icon(6.30 MB)
11Colorectal CancerPDF Icon(12.12 MB)
12Esophageal CancerPDF Icon(3.88 MB)
13Gastric CancerPDF Icon(24.88 MB)
14Gallbladder CancerPDF Icon(7.48 MB)
15Larynx and Hypopharynx CancersPDF Icon(8.07 MB)
16MSS Myelodysplastic Syndrome (MDS)PDF Icon(6.07 MB)
17Multiple MyelomaPDF Icon(13.36 MB)
18Non-Hodgikin's Lymphoma (High Grade)PDF Icon(5.50 MB)
19Prostate CancerPDF Icon(11.9) MB
20RetinoblastomaPDF Icon(15.4) MB
21Ovarian_CancerPDF Icon(4.46 MB) MB
22Soft Tissue Sarcoma and OsteosarcomaPDF Icon(6.89 MB)
23Standard Operating Procedures for Immunophenotyping of Hematolymphoid NeoplasmsPDF Icon(5.58 MB)
24Standard Operating Procedures for Immunophenotyping of Hematolymphoid NeoplasmsPDF Icon(5.58 MB)
25Tongue CancerPDF Icon(10.30 MB)
26Uterine CancerPDF Icon(3.96 MB)
Sr. No.TitleDocument
1ICMR Guideline on Diagnosis and Management of Celiac DiseasePDF Icon(4.87 MB)
Sr. No.TitleDocument
1Guidelines on Code of Conduct for Research Scientists engaged in field of Life SciencesPDF Icon(47.78 KB)
Sr. No.TitleDocument
1Guidelines for CondemnationPDF Icon(209.73 KB)
Sr. No.TitleDocument
1ICMR- Good Clinical Laboratory Practices (GCLP)-2021PDF Icon(2.37 MB)
2ICMR- Good Clinical Laboratory Practices (GCLP)-2008PDF Icon(2.02 MB)
Sr. No.TitleDocument
1National Guidelines for Data Quality in SurveysPDF Icon(14.4 MB)
Sr. No.TitleDocument
1Guidance on Ethical Requirements for Laboratory Validation Testing (2024)PDF Icon(530 KB)
2Ethical Requirements for Systematic Review & Meta-Analysis Proposals - An Addendum (2024)PDF Icon(533 KB)
3Joint MoHFW-ICMR Guidelines for Ethical Use of Leftover De-identified/ Anonymous Samples for Commercial Purpose (2024)PDF Icon(1.19 MB)
4Policy statement for the Ethical Conduct of Controlled Human Infection Studies (CHIS) in India (2023)PDF Icon(6.79 MB)
5Guidelines for ICMR Network of Institutions: Joint Ethics Review of Multicentre Research (2023)PDF Icon(895 KB)
6Ethical Guidelines for Application of Artificial Intelligence in Biomedical Research and Healthcare (2023)PDF Icon(30.2 MB)
7ICMR Consensus Guidelines on ‘Do Not Attempt Resuscitation’. Natl Med J India, DOI: 10.4103/0970-258X.284970 (2020)PDF Icon(377 KB)
8ICMR Consensus Guidelines on ‘Do Not Attempt Resuscitation’. Indian Journal of Medical Research. 2020 Apr 1;151(4):303., DOI: 10.4103/ijmr.IJMR_395_20 (2020)PDF Icon(3.07 MB)
9Guidelines National Guidelines for Ethics Committees Reviewing Biomedical & Health Research During COVID-19 Pandemic-April (2020)PDF Icon(1.33 MB)
10SOP Template for Ethics Review of Biomedical and Health Research During Covid-19 Pandemic (2020)PDF Icon(1.33 MB)
11ICMR Policy on Research Integrity and Publication Ethics (RIPE) (2019)PDF Icon(2.84 MB)
12Common Forms for Ethics Committee ReviewPDF Icon(297.31 KB)
13Handbook on National Ethical Guidelines for Biomedical and Health Research Involving Human Participants (2018)PDF Icon(297.31 KB)
14National Ethical Guidelines for Bio-Medical Research Involving Children (2017)PDF Icon(1.35 MB)
15National Ethical Guidelines for Biomedical and Health Research Involving Human Participants (2017)PDF Icon(2.07 MB)
16Ethical Guidelines for Biomedical Research on Human Participants (2006)PDF Icon(3.15 MB)
17Ethical Guidelines for Biomedical Research on Human Subjects (2000)PDF Icon(395 KB)
18Policy Statement on Ethical Considerations Involved in Research on Human Subjects (1980)PDF Icon(3.7 MB)
Sr. No.TitleDocument
1National Guidelines for Gene Therapy Product Development & Clinical Trials (2019)PDF Icon(22.31 MB)
2Salient features of the National Guidelines for Gene Therapy Product Development and Clinical TrailsPDF Icon(23.55 KB)
Sr. No.TitleDocument
1Guidelines for Safety Assessment of Foods Derived from Genetically Engineered PlantsPDF Icon(1.41 MB)
Sr. No.TitleDocument
1Mapping, Size Estimation and Risk Behaviour Survey Among Key Population Groups in Virtual SpacePDF Icon(26.1 MB)
Sr. No.TitleDocument
1ICMR Brand Guidelines.PDF Icon(16.1 MB)
Sr. No.TitleDocument
1GuidelinesPDF Icon(2.72 MB)
2Evidence Summaries and Guideline Panel Decision TablesPDF Icon(2.46 MB) 
Sr. No.TitleDocument
1ICMR Intellectual Property PolicyPDF Icon(2.72 MB)
2ICMR Guidelines for Technology Development Collaboration ICMR Guidelines for Utilization of CSR FundsPDF Icon(2.46 MB) 
3ICMR Guidelines for Utilization of CSR FundsPDF Icon(2.46 MB) 
Sr. No.TitleDocument
1INOSA Guidelines Executive summaryPDF Icon(344.25 KB)
2in HindiPDF Icon(148.00 KB)
3Consensus and Evidence Based INOSA GUIDELINES 2014PDF Icon(842.32 KB)
Sr. No.TitleDocument
1Drug policy for p.falciparum Malaria in NothEastern StatesPDF Icon(20.91 KB)
Sr. No.TitleDocument
1CDSCO, DBT and ICMR Joint Guidelines for Evaluation of Nanopharmaceuticals in IndiaPDF Icon(1.95 MB)
Sr. No.TitleDocument
1Guidelines for National Health Research Priority ProjectsPDF Icon(1.59 MB)
Sr. No.TitleDocument
1'ICMR-DBT' Guidelines for evaluation of probiotics in foodPDF Icon(144.00 KB)
Sr. No.TitleDocument
1Revised Common Protocol for Uniform Evaluation of Public Health Pesticides including Bio-larvicides for use in Vector ControlPDF Icon(2.25 MB)
2Standard Operating Procedure (SOP) for introduction of public Health Pesticides including Biolarvicides in the National Vector CPDF Icon(2.25 MB)
Sr. No.TitleDocument
1ICMR Guidelines on diagnosis and management of Rickettsial diseases in IndiaPDF Icon(2.10 MB)
2Standard Operating Procedure (SOP) for introduction of public Health Pesticides including Biolarvicides in the National Vector CPDF Icon(2.25 MB)
Sr. No.TitleDocument
1National Guidelines in the Management of RetinoblastomaPDF Icon(34.07 MB)
Sr. No.TitleDocument
1Guidelines for Umbilical Cord Blood Banking: Collection, Processing, Testing, Storage, Banking and Release for Clinical Application (2023)PDF Icon(2.8 MB)
2Evidence Based Status of SCT for Amyotrophic Lateral Sclerosis and Motor Neuron diseasesPDF Icon(596 KB)
3Evidence Based Status of SCT for Autism Spectrum DisorderPDF Icon(693 KB)
4Evidence Based Status of SCT for Critical Limb IschemiaPDF Icon(521 KB)
5Evidence Based Status of SCT for Duchenne Muscular DystrophyPDF Icon(614 KB)
6Evidence Based Status of SCT for Heart FailurePDF Icon(616 KB)
7Evidence Based Status of SCT for Lysosomal Storage DiseasesPDF Icon(762 KB)
8Evidence Based Status of SCT for Multiple SclerosisPDF Icon(515 KB)
9Evidence Based Status of SCT for Spinal Cord InjuryPDF Icon(246 KB)
10Evidence Based Status of SCT for StrokePDF Icon(517 KB) 
11National Guidelines for Hematopoietic Cell Transplantation (2021)PDF Icon(1.19 MB)
12Evidence Based Status of Stem Cell Therapy for Human Diseases (2021)PDF Icon(1.19 MB)
13National Guidelines for Stem Cell Research (2017)PDF Icon(7.13 MB)
14Guidelines for Stem Cell Research (2013)PDF Icon(2.27 MB)
15Guidelines for Stem Cell Research(2007)PDF Icon(831.63 KB)
Sr. No.TitleDocument
1Technology Transfer and Revenue SharingPDF Icon(1.75 KB)
Sr. No.TitleDocument
1Guidelines for processing Transational Research Projects submitted by the ICMR InstitutesPDF Icon(3.94 MB)
Sr. No.TitleDocument
1Guidelines for Management of Type 1 DiabetesPDF Icon(9.72 MB)
Sr. No.TitleDocument
1Guidelines for Management of Type 2 DiabetesPDF Icon(9.72 MB)